Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$61.30
Open:$60.89
Day's Low:$60.22
Day's High:$61.23
Bid / Ask:-
Market Cap:11.57B
Enterprise Value:14.30B
52-Week Range
52-Week Low:$51.01
52-Week High:$89.83
Current position in 52-week range
52w Low-52w High
50-Day Avg:$60.03
200-Day Avg:$68.79
Volume
Volume Today:2,203,950
Avg Volume (3m):3,473,093
Avg Volume (10d):2,986,840
52-Week Change:-11.26%
vs S&P 500, 52 weeks:-
Beta:0.82
Valuation Multiples
P/E (trailing):20.83
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 9, 2026. The P/E is the price divided by that EPS.
P/E (forward):12.96
PEG Ratio:0.58
Price / Book:1.39
Price / Sales (TTM):2.73
EV / Revenue:3.38
EV / EBITDA:15.35
Dividends
Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:0.01%
Payout Ratio:0.00%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):4.24B
Gross Profit:2.79B
EBITDA:932.00M
Net Income (TTM):570.30M
Rev Growth (YoY):+0.60%
Earnings Growth (YoY):+357.10%
Quarterly earnings growth (YoY):+340.30%
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$2.92
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 9, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$4.69
Revenue Per Share:$21.69
Cash Per Share:-
Book Value:$43.81
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:154.70M
Total Debt:2.80B
Net Debt (Debt - Cash):2.65B
Debt / Equity:33.63%
Current Ratio:1.22
Quick Ratio:0.51
Cash Flows
Operating Cash Flow:1.03B
Free Cash Flow (FCF):542.65M
FCF Yield (FCF / Market Cap):-
Enterprise Value:14.30B
EV / Revenue:3.38
EV / EBITDA:15.35
Profitability
ROE (Return on Equity):6.84%
ROA (Return on Assets):2.74%
P/E (trailing):20.83
P/E (forward):12.96
Price / Book:1.39
PEG Ratio:0.58
52-Week Change:-11.26%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$2.92
Diluted EPS for the last 12 months: the four quarters ended Jul 31, 2026, from the accounts filed with the SEC on Sep 9, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$4.69
P/E (forward):12.96
PEG Ratio:0.58
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$21.69
Cash Per Share:-
Book Value:$43.81
Cash Flows (TTM)
Free Cash Flow:542.65M
Operating Cash Flow:1.03B
EBITDA:932.00M
Total Revenue (TTM):4.24B
Net Income (TTM):570.30M
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:190,155,294
Float (free shares):188,767,160
Short interest (shares):9,088,308
Short % of float:-
Short Ratio (days to cover):2.03
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
The Cooper Companies, Inc. (COO) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Vice President of Investor Relations & Risk Management
-
-
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
The Cooper Companies, Inc. (COO): Quantitative Analysis
The Cooper Companies, Inc. (COO) — Healthcare — Medical Instruments & Supplies. COO is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, COO has returned −25.8% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
COO ranks 270 of 461 on today's multifactor score, and 37 of the 55 Healthcare companies that score. Its strongest factor is value (Z 0.41, ranked 111 of 489); its weakest is momentum (Z -0.93, ranked 414 of 494). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
Frequently asked questions about Cooper Companies (COO)
When does Cooper Companies report earnings?
According to Nasdaq's public calendar (checked on Nov 4, 2026), Cooper Companies will report its next earnings on Dec 3, 2026, with no time announced. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 11 after the close (and 1 with no time on the filing) (SEC filings through Sep 9, 2026). COO earnings dates and times, quarter by quarter →
What is Cooper Companies's P/E ratio?
Cooper Companies's P/E (price over earnings per share for the last twelve months) is 20.8 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jul 31, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Cooper Companies is below its sector median. Healthcare stocks, company by company →
Where does Cooper Companies rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Cooper Companies ranks 270 of 461, and 37 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Cooper Companies insiders bought or sold shares?
The latest open-market purchase of Cooper Companies shares filed with the SEC (Form 4) was on Sep 16, 2026, by a director, for $549k. Nor any open-market sale. In total, from August 2025 through Nov 3, 2026: 15 purchases and 0 sales by directors, officers and large shareholders. All COO insider trades →
What sector is Cooper Companies in, and which index?
Cooper Companies is classified in the Healthcare sector (industry: Medical Instruments & Supplies), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.